Vaccinating Pregnant Women Protects Infants Against Severe RSV
The vaccine RSVpreF had an almost 82% efficacy against severe RSV infection in infants from birth through the first 90 days of life, according to company data.
Source: medscape.com
Stay updated with breaking news from Ediatric Common Col. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The vaccine RSVpreF had an almost 82% efficacy against severe RSV infection in infants from birth through the first 90 days of life, according to company data.